Improving the standard of care for people living with liver disease
Hepatic Health represents a new educational resource from Gilead Sciences and is designed to meet the educational needs of healthcare professionals and people with an interest in the field of liver disease; particularly with regard to chronic hepatitis C virus (HCV) infection and hepatitis B virus (HBV) infection.
Hepatic Health is a reflection of Gilead’s ongoing commitment to advancing the care of people with liver disease.
Simplification and Test and Treat Strategies Towards Hepatitis C Elimination
The investigator-sponsored research program ‘Simplification and Test and Treat Strategies Towards Hepatitis C Elimination’ (STAT) aims to support research projects focused on ways to overcome barriers in hepatitis C (HCV) care.
The importance of clinical context in hepatitis B screening
In an exclusive interview for Hepatic Health, Dr Patrick Kennedy, consultant hepatologist, discusses the importance of clinical context when diagnosing hepatitis B (HBV). In the article and video, Dr Kennedy explains the need for further investigation when presented with abnormal liver function test (LFTs) results, and why clinical context can mean normal LFT results warrant more exploration.
Looking for in-depth information on liver disease?
Background on the global and local burden of HCV; the expanding role of primary care in HCV management; diagnosis and pre-treatment assessment; HCV treatment and ongoing care. The important role of hepatitis nurses in the HCV care pathway is also discussed.
The aim of this section is to summarise the most recent data on NAFLD and NASH including the burden, staging, diagnosis and management approaches such as lifestyle interventions and multidisciplinary management.
Providing relevant information across the care continuum
Hepatic Health can assist healthcare professionals of many specialties, including:
Primary care providers
All aspects of screening, evaluation and treatment of HCV, HBV, NAFLD and NASH with progressive fibrosis are addressed, including expert insights on complex issues and scientific updates from annual meetings.
Gilead R&D has helped advance the treatment of chronic hepatitis C infection and help manage chronic hepatitis B infection. Today, the company’s liver disease research focuses on advancing the care of patients living with liver diseases through its research and development efforts.